Travere Therapeutics granted RSUs to new employees vesting over four years

From GlobeNewswire: 2024-09-12 17:00:00

Travere Therapeutics, Inc. granted 33,500 shares of common stock as inducement RSUs to six new employees. These RSUs vest over four years, with 25% of the shares vesting on each anniversary of the grant date, contingent upon the employees’ continued service with the company. Travere Therapeutics focuses on developing therapies for rare diseases and collaborates with the rare disease community to provide life-changing treatments. For more information, visit travere.com. Media contact: 888-969-7879, [email protected]. Investor contact: 888-969-7879, [email protected].



Read more at GlobeNewswire: Travere Therapeutics Reports Inducement Grants Under Nasdaq